Statistics for ABL Diagnostics Société anonyme (id:11029 ABLD)
Valuation metrics
Market cap
46.04M
Enterprise value
47.33M
Trailing P/E (ttm)
27.00
Forward P/E
11.83
PEG ratio
Price/Sales (ttm)
7.44
Price/Book (mrq)
6.81
Enterprise Value/Revenue
7.65
Enterprise Value/EBITDA
110.36
Overview
Shares outstanding
16.10M
Float
875.15K
Shares short
% Held by insiders
1.00%
% Held by institutions
0.00%
Average volume (10 days)
4.00
Average volume (90 days)
Price summary
52-Week low
2.70
52-Week high
9.70
52-Week change
-241.55%
Beta
-0.23
50-Day moving average
2.84
200-Day moving average
3.63
Dividends and splits
Forward annual dividend rate
1.12
Forward annual dividend yield
0.39
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
October 01th, 2020
Last split factor
2:1
Last split date
May 18th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2022
Profitability
Profit margin
0.88%
Operating margin
-16.17%
Operational effectiveness
Return on assets
-0.96%
Return on equity
0.80%
Income statement
Revenue (ttm)
0.38
Revenue per share (ttm)
0.38
Quarterly revenue growth (yoy)
-0.94
Gross profit (ttm)
4.88M
EBITDA
6.91B
Net income to common (ttm)
54.36K
Diluted EPS (ttm)
0.00
Quarterly earnings growth (yoy)
-93.90%
Balance sheet
Total cash (mrq)
2.23M
Total cash per share (mrq)
0.14
Total debt (mrq)
3.47M
Total Debt/Equity (mrq)
51.26
Current ratio (mrq)
198.90%
Book value per share (mrq)
0.42
Cash flow
Cash flow statement
257.87K
Levered free cash flow (LFCF)
54.36K